FDA.reportPublic FDA data

POLYSORBATE 80

Substance profile for UNII 6OZP39ZG8H, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
6OZP39ZG8H
Preferred term
POLYSORBATE 80
Registry number
9005-65-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
8560
PubChem
0
NCIt
C80656
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm8560mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=8560
NCI ThesaurusC80656ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80656
FDA Substance Registration System6OZP39ZG8Hprecision.fda.gov/uniisearch/srs/unii/6OZP39ZG8H

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENTBenePatch (69418-002)11
INACTIVE INGREDIENTAmeriPatch (69418-003)10
INACTIVE INGREDIENTLANSOPRAZOLE7
INACTIVE INGREDIENTCARVEDILOL - carvedilol tablet Sun Pharmaceutical Industries, Inc. These highlights do not include all the information needed to use Carvedilol Tablets safely and effectively. See full prescribing information for Carvedilol Tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 199513
INACTIVE INGREDIENTThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19969
INACTIVE INGREDIENTDrug Facts8
INACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENTCYCLOBENZAPRINE HYDROCHLORIDE TABLETS, USP Rx only11
INACTIVE INGREDIENTParoxetine Hydrochloride Controlled-Release Tablets1000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for Prevacid: PREVACID (lansoprazole) delayed-release capsules, for oral use PREVACID SoluTab (lansoprazole) delayed-release orally disintegrating tablets, for oral use Initial U.S. Approval: 19951000
INACTIVE INGREDIENTNAMMAN MUAY Athlete's Pain Relieving Liniment10
INACTIVE INGREDIENTKiss Fungi-Gone Antifungal Treatment - Drug Facts10
INACTIVE INGREDIENTThese highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules Omeprazole delayed-release capsules, USP, for oral administration Initial U.S. Approval: 198912
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Oxcarbazepine safely and effectively. See full prescribing information for Oxcarbazepine Tablets. Oxcarbazepine Tablets Initial U.S. Approval: 200014
INACTIVE INGREDIENTRenovo Patch8
INACTIVE INGREDIENTSertraline Tablets, USP 25 mg, 50 mg and 100 mg Rx Only27
INACTIVE INGREDIENTThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for Carvedilol Tablets, USP. Carvedilol Tablets, USP film coated for oral use Initial U.S. Approval: 199511
INACTIVE INGREDIENTPovidone Iodine Scrub8
INACTIVE INGREDIENTVida Mia Hand Sanitizer (62%) 2oz.7
INACTIVE INGREDIENTMedrox Patch14
INACTIVE INGREDIENTAspirin EC 81 mg17
INACTIVE INGREDIENTbB MEDICATED PAIN RELIEVING OIL APPLY ON SKIN ONLY8
INACTIVE INGREDIENTAmiodarone HCl 450 mg Added to 5% Dextrose 250 mL Bag8
INACTIVE INGREDIENTThese highlights do not include all the information needed to use FORTICAL ® safely and effectively. See full prescribing information for FORTICAL. FORTICAL ® (calcitonin-salmon [rDNA origin]) Nasal Spray for intranasal use Initial U.S. Approval: 200510
INACTIVE INGREDIENTThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951001
INACTIVE INGREDIENTDILTIAZEM HYDROCHLORIDE Extended-release Capsules, USP1001
INACTIVE INGREDIENTThese highlights do not include all the information needed to use eszopiclone safely and effectively. See full prescribing information for eszopiclone tablets. Eszopiclone Tablets for oral use CIV Initial U.S. Approval: 20041001
INACTIVE INGREDIENTThese highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. AMLODIPINE besylate and BENAZEPRIL hydrochloride capsules for oral use Initial U.S. Approval: 19951000
INACTIVE INGREDIENTRopinirole Hydrochloride Tablets Rx only PRESCRIBING INFORMATION Patient Information Included1000
INACTIVE INGREDIENTTramadol Hydrochloride Tablets, USP11
INACTIVE INGREDIENTThese highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. Amlodipine Besylate and Benazepril Hydrochloride Capsules Initial U.S. Approval: 19951001
INACTIVE INGREDIENTThese highlights do not include all the information needed to use OXYCODONE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for OXYCODONE HCl EXTENDED-RELEASE TABLETS. OXYCODONE HCl EXTENDED-RELEASE TABLETS, for oral use, CII Initial U.S. Approval: 195010
INACTIVE INGREDIENTClarithromycin for Oral Suspension, USP7
INACTIVE INGREDIENTThese highlights do not include all the information needed to use PRASTERA ® safely and effectively. See full prescribing information for PRASTERA ® . PRASTERA ® prasterone oral softgels 200mg are for oral use only. Initial U.S. Approval13
INACTIVE INGREDIENTSERTRALINE HYDROCHLORIDE Tablets and Oral Concentrate8
INACTIVE INGREDIENTFluphenazine Hydrochloride Tablets, USP14
INACTIVE INGREDIENTAMITRIPTYLINE HYDROCHLORIDE TABLETS, USP Rx only13
INACTIVE INGREDIENTMenthol 5% (Topical Analgesic)17
INACTIVE INGREDIENTba11070e-1a36-4d5d-9e48-c37b4e90c0377
INACTIVE INGREDIENTd327b4ea-a232-4102-bd74-141196f687e08
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Zolpidem Tartrate Tablets safely and effectively. See full prescribing information for Zolpidem Tartrate Tablets. Zolpidem Tartrate Tablets for oral administration C-IV Initial U.S. Approval: 19929
INACTIVE INGREDIENTOral Defense Fluoride Rinse12
INACTIVE INGREDIENTSkin-firm Lipoamino Hydrator SPF1511
INACTIVE INGREDIENTKaranja Tree Sunshield SPF309
INACTIVE INGREDIENTAspirin NSAIDS EC Tablet 325mg- 5gr9
INACTIVE INGREDIENTPerrigo Heartburn Relief Drug Facts1000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use VALTREX safely and effectively. See full prescribing information for VALTREX. VALTREX (valacyclovir hydrochloride) Caplets Initial U.S. Approval: 19951000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19961000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951000
INACTIVE INGREDIENTBisoprolol Fumarate and Hydrochlorothiazide Tablets1000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets for oral use Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs, levofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.1000
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Amlodipine Besylate and Benazepril Hydrochloride Capsules safely and effectively. See full prescribing information for Amlodipine Besylate and Benazepril Hydrochloride Capsules . A mlodipine B esylate and B enazepril H ydrochloride Capsules Initial U.S. Approval: 199511
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Metoprolol Succinate Extended-Release Tablets USP safely and effectively. See full prescribing information for Metoprolol Succinate Extended-Release Tablets USP. Metoprolol Succinate Extended-Release Tablets USP Initial U.S. Approval: 19927
INACTIVE INGREDIENTOral Defense Mouth Rinse17
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Amlodipine Besylate and Benazepril Hydrochloride Capsules safely and effectively. See full prescribing information for Amlodipine Besylate and Benazepril Hydrochloride Capsules . A mlodipine B esylate and B enazepril H ydrochloride Capsules Initial U.S. Approval: 199512
INACTIVE INGREDIENTDrug Facts7
ACTIVE INGREDIENTDrug Facts17
INACTIVE INGREDIENTINFUVITE ® ADULT Multiple Vitamins for Infusion10
INACTIVE INGREDIENTWelby 44-1908
INACTIVE INGREDIENTThese highlights do not include all the information needed to use valacyclovir hydrochloride tablets safely and effectively. See full prescribing information for valacyclovir hydrochloride tablets. Valacyclovir hydrochloride tablets Initial U.S. Approval: 19957
INACTIVE INGREDIENTProchlorperazine Maleate Tablets, USP12
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Medroxyprogesterone Acetate Injectable Suspension, USP safely and effectively. See full prescribing information for Medroxyprogesterone Acetate Injectable Suspension, USP. Medroxyprogesterone Acetate Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 19597
INACTIVE INGREDIENTDrug Facts9
INACTIVE INGREDIENTTherabenzaprine-909
INACTIVE INGREDIENTNabumetone - Par13
INACTIVE INGREDIENTThese highlights do not include all the information needed to use GLUMETZA safely and effectively. See full prescribing information for GLUMETZA. GLUMETZA ® (metformin hydrochloride extended-release tablets), 500 mg and 1000 mg Initial U.S. Approval: 199514
INACTIVE INGREDIENTCold Spot Point Relief Pain relieving Gel - 32 oz.10
INACTIVE INGREDIENTRECOMBINATE [Antihemophilic Factor (Recombinant)]7
INACTIVE INGREDIENTTEMPRA (ACETAMINOPHEN) TABLET [BRISTOL-MYERS SQUIBB DE MEXICO, S. DE R.L. DE C.V.]20155
INACTIVE INGREDIENTLEVAQUIN (LEVOFLOXACIN) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]4005
INACTIVE INGREDIENTCITALOPRAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3973
INACTIVE INGREDIENTHYDROXYZINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3961
INACTIVE INGREDIENTTRIAMCINOLONE ACETONIDE CREAM [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3960
INACTIVE INGREDIENTPREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3956
INACTIVE INGREDIENTZOLPIDEM TARTRATE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3937
INACTIVE INGREDIENTTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN TABLET, COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3933
INACTIVE INGREDIENTONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3925
INACTIVE INGREDIENTAMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3870
INACTIVE INGREDIENTVERAMYST (FLUTICASONE FUROATE) SPRAY, METERED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3835
INACTIVE INGREDIENTTRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3834
INACTIVE INGREDIENTFENOFIBRATE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3813
INACTIVE INGREDIENTZOLOFT (SERTRALINE HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3774
INACTIVE INGREDIENTZYPREXA (OLANZAPINE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3719
INACTIVE INGREDIENTULTRAM (TRAMADOL HYDROCHLORIDE) TABLET, COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3685
INACTIVE INGREDIENTULTRACET (TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3679
INACTIVE INGREDIENTVALTREX (VALACYCLOVIR HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3676
INACTIVE INGREDIENTFLUTICASONE PROPIONATE SPRAY, METERED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3639
INACTIVE INGREDIENTEVISTA (RALOXIFENE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3626
INACTIVE INGREDIENTFLURBIPROFEN TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3626
INACTIVE INGREDIENTLIPITOR (ATORVASTATIN CALCIUM) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3617
INACTIVE INGREDIENTNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE SUSPENSION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3509
INACTIVE INGREDIENTOXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3474
INACTIVE INGREDIENTBUPROPION HYDROCHLORIDE EXTENDED RELEASE SR (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3473
INACTIVE INGREDIENTNEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3473
INACTIVE INGREDIENTETODOLAC TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3455
INACTIVE INGREDIENTCLARITHROMYCIN TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3350
INACTIVE INGREDIENTVENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3320
INACTIVE INGREDIENTPROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3263
INACTIVE INGREDIENTHYDROXYZINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3256
INACTIVE INGREDIENTIBU (IBUPROFEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3242
INACTIVE INGREDIENTIBU (IBUPROFEN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3239
INACTIVE INGREDIENTCOREG (CARVEDILOL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3236
INACTIVE INGREDIENTSPIRONOLACTONE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3169
INACTIVE INGREDIENTOPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3165
INACTIVE INGREDIENTGABAPENTIN TABLET [LAKE ERIE MEDICA & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3163
INACTIVE INGREDIENTFLECTOR (DICLOFENAC EPOLAMINE ) PATCH [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3142
INACTIVE INGREDIENTAMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3129
INACTIVE INGREDIENTOXYCONTIN (OXYCODONE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2101
INACTIVE INGREDIENTMS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2084
INACTIVE INGREDIENTZIPSOR (DICLOFENAC POTASSIUM) CAPSULE, LIQUID FILLED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS]2043
INACTIVE INGREDIENTHUMIRA (ADALIMUMAB) KIT HUMIRA (ADALIMUMAB) INJECTION, SOLUTION [ABBVIE INC.]1805
INACTIVE INGREDIENTKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
INACTIVE INGREDIENTNORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
INACTIVE INGREDIENTLUPRON DEPOT (LEUPROLIDE ACETATE) KIT [ABBVIE INC.]1488
INACTIVE INGREDIENTLUPRON DEPOT (LEUPROLIDE ACETATE) KIT [ABBVIE INC.]1447
INACTIVE INGREDIENTADVICOR (NIACIN AND LOVASTATIN) TABLET, EXTENDED RELEASE [ABBVIE INC.]1429
INACTIVE INGREDIENTTEVETEN (EPROSARTAN MESYLATE) TABLET [ABBVIE INC.]1428
INACTIVE INGREDIENTVICOPROFEN (HYDROCODONE BITARTRATE AND IBUPROFEN) TABLET, FILM COATED [ABBVIE INC.]1414
INACTIVE INGREDIENTKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
INACTIVE INGREDIENTGENGRAF (CYCLOSPORINE) CAPSULE [ABBVIE INC.]1209

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 6OZP39ZG8H page 1 of 1 · 78 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POLYSORBATE 806OZP39ZG8H9005656DROPSAURICULAR (OTIC)0.02 %w/w
POLYSORBATE 806OZP39ZG8H9005656SOLUTIONAURICULAR (OTIC)0.2 %w/w
POLYSORBATE 806OZP39ZG8H9005656SOLUTION/ DROPSAURICULAR (OTIC)13 mg
POLYSORBATE 806OZP39ZG8H9005656SUSPENSIONAURICULAR (OTIC)1 %w/v
POLYSORBATE 806OZP39ZG8H9005656INJECTIONINTRA-ARTICULAR4 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, POWDER, FOR SUSPENSIONINTRA-ARTICULAR5 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SUSPENSIONINTRA-ARTICULAR4 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTIONINTRALESIONAL4 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SUSPENSIONINTRALESIONAL4 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTIONINTRAMUSCULAR4 %w/v
POLYSORBATE 806OZP39ZG8H9005656INJECTION, POWDER, FOR SUSPENSIONINTRAMUSCULAR4 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAMUSCULAR1 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SOLUTIONINTRAMUSCULAR5 %w/v
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SUSPENSIONINTRAMUSCULAR4 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTIONINTRASYNOVIAL0.2 %w/v
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SUSPENSIONINTRASYNOVIAL4 mg
POLYSORBATE 806OZP39ZG8H9005656CONCENTRATEINTRAVENOUS4680 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTIONINTRAVENOUS4680 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS53 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS900 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SOLUTIONINTRAVENOUS1170 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SOLUTION, CONCENTRATEINTRAVENOUS4739 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SUSPENSIONINTRAVENOUS0.5 %w/v
POLYSORBATE 806OZP39ZG8H9005656LIQUIDINTRAVENOUS720 mg
POLYSORBATE 806OZP39ZG8H9005656SOLUTIONINTRAVENOUS900 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SUSPENSIONINTRAVITREAL0.02 %w/v
POLYSORBATE 806OZP39ZG8H9005656SPRAYNASAL0.01 mg
POLYSORBATE 806OZP39ZG8H9005656SPRAY, METEREDNASAL0.1 mg/1ml
POLYSORBATE 806OZP39ZG8H9005656DROPSOPHTHALMIC0.05 %w/w
POLYSORBATE 806OZP39ZG8H9005656EMULSIONOPHTHALMIC26 mg
POLYSORBATE 806OZP39ZG8H9005656SOLUTIONOPHTHALMIC8 mg
POLYSORBATE 806OZP39ZG8H9005656SOLUTION, GEL FORMING, EXTENDED RELEASEOPHTHALMIC0.05 %w/w
POLYSORBATE 806OZP39ZG8H9005656SOLUTION/ DROPSOPHTHALMIC0.25 %w/v
POLYSORBATE 806OZP39ZG8H9005656SUSPENSIONOPHTHALMIC1 mg
POLYSORBATE 806OZP39ZG8H9005656SUSPENSION/ DROPSOPHTHALMIC1 mg
POLYSORBATE 806OZP39ZG8H9005656CAPSULEORAL418.37 mg
POLYSORBATE 806OZP39ZG8H9005656CAPSULE, COATEDORAL0.04 mg
POLYSORBATE 806OZP39ZG8H9005656CAPSULE, COATED PELLETSORAL2 mg
POLYSORBATE 806OZP39ZG8H9005656CAPSULE, DELAYED RELEASEORAL23 mg
POLYSORBATE 806OZP39ZG8H9005656CAPSULE, EXTENDED RELEASEORAL10 mg
POLYSORBATE 806OZP39ZG8H9005656CAPSULE, LIQUID FILLEDORAL24 mg
POLYSORBATE 806OZP39ZG8H9005656CONCENTRATEORAL1 mg/1ml
POLYSORBATE 806OZP39ZG8H9005656ELIXIRORAL2.5 mg/15ml
POLYSORBATE 806OZP39ZG8H9005656GRANULE, FOR SUSPENSIONORAL240 mg
POLYSORBATE 806OZP39ZG8H9005656PASTEORAL28 mg
POLYSORBATE 806OZP39ZG8H9005656POWDERORAL66 mg
POLYSORBATE 806OZP39ZG8H9005656POWDER, FOR SUSPENSIONORAL396 mg
POLYSORBATE 806OZP39ZG8H9005656SOLUTIONORAL907 mg
POLYSORBATE 806OZP39ZG8H9005656SUSPENSIONORAL206 mg
POLYSORBATE 806OZP39ZG8H9005656SUSPENSION, EXTENDED RELEASEORAL40 mg
POLYSORBATE 806OZP39ZG8H9005656SUSPENSION/ DROPSORAL23 mg
POLYSORBATE 806OZP39ZG8H9005656TABLETORAL233 mg
POLYSORBATE 806OZP39ZG8H9005656TABLET, CHEWABLEORAL84 mg
POLYSORBATE 806OZP39ZG8H9005656TABLET, COATEDORAL18 mg
POLYSORBATE 806OZP39ZG8H9005656TABLET, DELAYED RELEASEORAL4 mg
POLYSORBATE 806OZP39ZG8H9005656TABLET, EXTENDED RELEASEORAL10 mg
POLYSORBATE 806OZP39ZG8H9005656TABLET, FILM COATEDORAL24 mg
POLYSORBATE 806OZP39ZG8H9005656TABLET, FILM COATED, EXTENDED RELEASEORAL8 mg
POLYSORBATE 806OZP39ZG8H9005656TABLET, ORALLY DISINTEGRATINGORAL1 mg
POLYSORBATE 806OZP39ZG8H9005656TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL34 mg
POLYSORBATE 806OZP39ZG8H9005656ENEMARECTAL0.01 %w/v
POLYSORBATE 806OZP39ZG8H9005656SOLUTIONRECTAL315 mg
POLYSORBATE 806OZP39ZG8H9005656SUPPOSITORYRECTAL72.15 mg
POLYSORBATE 806OZP39ZG8H9005656SUSPENSIONRESPIRATORY (INHALATION)1 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SUSPENSIONSOFT TISSUE4 mg
POLYSORBATE 806OZP39ZG8H9005656INJECTION, SUSPENSIONSUBCUTANEOUS0.3 %w/v
POLYSORBATE 806OZP39ZG8H9005656SUSPENSIONSUBCUTANEOUS0.3 %w/v
POLYSORBATE 806OZP39ZG8H9005656TABLETSUBLINGUAL0.08 mg
POLYSORBATE 806OZP39ZG8H9005656AEROSOL, FOAMTOPICAL0.98 %w/w
POLYSORBATE 806OZP39ZG8H9005656CREAMTOPICAL20 mg
POLYSORBATE 806OZP39ZG8H9005656EMULSIONTOPICAL34050 mg
POLYSORBATE 806OZP39ZG8H9005656GELTOPICAL12 mg
POLYSORBATE 806OZP39ZG8H9005656LOTIONTOPICAL15 %w/w
POLYSORBATE 806OZP39ZG8H9005656OINTMENTTOPICAL0.1 %w/w
POLYSORBATE 806OZP39ZG8H9005656SYSTEMTOPICAL28 mg
POLYSORBATE 806OZP39ZG8H9005656AEROSOL, FOAMVAGINAL3 %w/w
POLYSORBATE 806OZP39ZG8H9005656CREAMVAGINAL0.4 %w/w
POLYSORBATE 806OZP39ZG8H9005656SUPPOSITORYVAGINAL28 mg